文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy.

作者信息

Richter Joel E

机构信息

Dr Richter is a professor of medicine, the Hugh F. Culverhouse Chair for Esophagology, director of the Division of Digestive Diseases and Nutrition, and director of the Joy McCann Culverhouse Center for Swallowing Disorders at the University of South Florida Morsani College of Medicine in Tampa, Florida.

出版信息

Gastroenterol Hepatol (N Y). 2014 Sep;10(9):547-55.


DOI:
PMID:27551249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4991531/
Abstract

Suspected reflux symptoms that are refractory to proton pump inhibitors (PPIs) are rapidly becoming the most common presentation of gastroesophageal reflux disease (GERD) in patients seen in gastroenterology clinics. These patients are a heterogeneous group, differing in symptom frequency and severity, PPI dosing regimens, and responses to therapy (from partial to absent). Before testing, the physician needs to question the patient carefully about PPI compliance and the timing of drug intake in relation to meals. Switching PPIs or doubling the dose is the next step, but only 20% to 25% of the group refractory to PPIs will respond. The first diagnostic test should be upper gastrointestinal endoscopy. In more than 90% of cases, the results will be normal, but persistent esophagitis may suggest pill esophagitis, eosinophilic esophagitis, or rarer diseases, such as lichen planus, Zollinger-Ellison syndrome, or genotype variants of PPI metabolism. If the endoscopy results are normal, esophageal manometry and especially reflux testing should follow. Whether patients should be tested on or off PPI therapy is controversial. Most physicians prefer to test patients off PPIs to identify whether abnormal acid reflux is even present; if it is not, PPIs can be stopped and other diagnoses sought. Testing patients on PPI therapy allows nonacid reflux to be identified, but more than 50% of patients have a normal test result, leaving the clinician with a conundrum-whether to stop PPIs or continue them because the GERD is being treated adequately. Alternative diagnoses in patients with refractory GERD and normal reflux testing include achalasia, eosinophilic esophagitis, gastroparesis, rumination, and aerophagia. However, more than 50% will be given the diagnosis of functional heartburn, a visceral hypersensitivity syndrome. Treating patients with PPI-refractory GERD-like symptoms can be difficult and frustrating. Any of the following may help: a histamine-2 receptor antagonist at night, baclofen to decrease transient lower esophageal sphincter relaxations, pain modulators, acupuncture, or hypnotherapy. At this time, antireflux surgery should be limited to patients with abnormal acid reflux defined by pH testing and a good correlation of symptoms with acid reflux.

摘要

相似文献

[1]
Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy.

Gastroenterol Hepatol (N Y). 2014-9

[2]
ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?

Arq Gastroenterol. 2018-11

[3]
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.

Dis Esophagus. 2012-8-2

[4]
Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.

Gastroenterol Clin North Am. 2020-9

[5]
Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo wireless esophageal pH monitoring study.

Rev Gastroenterol Mex. 2017

[6]
AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.

Clin Gastroenterol Hepatol. 2023-6

[7]
Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.

Indian J Gastroenterol. 2020-4

[8]
Refractory GERD: what is it?

Curr Gastroenterol Rep. 2008-6

[9]
Refractory Gastroesophageal Reflux Disease: A Management Update.

Front Med (Lausanne). 2021-11-1

[10]
Management of the patient with incomplete response to PPI therapy.

Best Pract Res Clin Gastroenterol. 2013-6

引用本文的文献

[1]
Clinical profile and characteristics of eosinophilic esophagitis patients presenting with refractory gastroesophageal reflux disease in Makassar, Indonesia.

Pan Afr Med J. 2022

[2]
Laryngopharyngeal Reflux: A State-of-the-Art Algorithm Management for Primary Care Physicians.

J Clin Med. 2020-11-10

[3]
The Spectrum of Reflux Phenotypes.

Gastroenterol Hepatol (N Y). 2019-12

[4]
The high frequency of esophageal disorders in Iranian patients with non-cardiac chest pain.

Gastroenterol Hepatol Bed Bench. 2018

[5]
Comparison of Esophageal Function Tests in Chinese Patients with Functional Heartburn and Reflux Hypersensitivity.

Gastroenterol Res Pract. 2017

[6]
The management of gastro-oesophageal reflux disease.

Aust Prescr. 2016-2

本文引用的文献

[1]
Surgical treatment of GERD: where have we been and where are we going?

Gastroenterol Clin North Am. 2014-3

[2]
Objective manometric criteria for the rumination syndrome.

Am J Gastroenterol. 2013-12-24

[3]
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel.

J Am Coll Surg. 2013-8-21

[4]
Guidelines for the diagnosis and management of gastroesophageal reflux disease.

Am J Gastroenterol. 2013-3

[5]
Increased prandial air swallowing and postprandial gas-liquid reflux among patients refractory to proton pump inhibitor therapy.

Clin Gastroenterol Hepatol. 2013-1-30

[6]
Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.

Gut. 2012-6-8

[7]
The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis.

Clin Gastroenterol Hepatol. 2012-5-18

[8]
Many patients continue using proton pump inhibitors after negative results from tests for reflux disease.

Clin Gastroenterol Hepatol. 2012-2-22

[9]
Alternative therapeutic approaches to chronic proton pump inhibitor treatment.

Clin Gastroenterol Hepatol. 2011-12-16

[10]
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded.

J Neurogastroenterol Motil. 2011-10-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索